Recombinant interferon beta in chronic myelogenous leukemia.
Aulitzky
W E
WE
Department of Internal Medicine, Johannes-Gutenberg University Medical Center, Mainz, Germany.
Després
D
D
Rudolf
G
G
Aman
J
J
Peschel
C
C
Huber
C
C
D002986:Clinical Trials as Topic; D016207:Cytokines / Q000235:genetics; D019204:GTP-Binding Proteins; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000473:pathology; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D064547:Myxovirus Resistance Proteins; D011506:Proteins / Q000235:genetics; D011994:Recombinant Proteins / Q000627:therapeutic use
D016207:Cytokines; D064547:Myxovirus Resistance Proteins; D011506:Proteins; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016899:Interferon-beta; D019204:GTP-Binding Proteins